Atopic dermatitis is a common, chronic, immune-mediated disease associated with several
comorbidities. Elevated levels of T helper (Th) 2, Th22, and also some Th1 and Th17 …

Atopic dermatitis (AD) is one of the most common inflammatory skin conditions. The
pathogenesis of AD involves skin barrier disruption and immune activation of T-helper (TH) …

Atopic dermatitis (AD) is a common chronic inflammatory skin condition that has a significant
impact on a patient's quality of life and requires ongoing management. Conventional topical …

Atopic dermatitis (AD) is a common, chronic, inflammatory skin disorder with high physical
and emotional burden. Robust evidence suggests that interleukin (IL)-4 and IL-13 are key …

Atopic dermatitis is a common, chronic and recurrent inflammatory skin disease, which often
appears in childhood but can last into adulthood. It negatively impacts patients, their families …

A 33-year-old man with severe atopic dermatitis (AD) since childhood was treated with
dupilumab as per the licensed indication. He had previously been treated with …

Dupilumab: short-term effectiveness and security in real clinical practice - A retrospective
multicentric study. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …

Purpose To identify the incidence, risk factors, demographics, and clinical profile of
dupilumab-induced ocular surface disease (DIOSD) in patients with atopic dermatitis (AD) …

Atopic dermatitis (AD) is a common skin condition characterized by inflammation that
presents with erythematous and pruritic skin. Its chronic relapse-remitting nature has a …

Introduction Chronic recurrent skin inflammation and severe itching in patients with atopic
dermatitis (AD) significantly impair their quality of life. The H4 histamine receptor plays a key …